Cargando…

Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma

Malignant mesothelioma (MM) is a fatal disease in dire need of therapy. The role of inflammasomes in cancer is not very well studied, however, literature supports both pro-and anti-tumorigenic effects of inflammasomes on cancer depending upon the type of cancer. Asbestos is a causative agent for MM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westbom, Catherine, Thompson, Joyce K., Leggett, Alan, MacPherson, Maximilian, Beuschel, Stacie, Pass, Harvey, Vacek, Pamela, Shukla, Arti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687055/ https://www.ncbi.nlm.nih.gov/pubmed/26689911 http://dx.doi.org/10.1371/journal.pone.0145404

Ejemplares similares

Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
por: Thompson, Joyce K., et al.
Publicado: (2017)

Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
por: Shukla, Arti, et al.
Publicado: (2010)

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2013)

Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
por: Thompson, Joyce K, et al.
Publicado: (2014)

Exosomal miR-16-5p as a target for malignant mesothelioma
por: Munson, Phillip B., et al.
Publicado: (2019)

Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts
por: Macura, Sherrill L, et al.
Publicado: (2013)

Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
por: Newick, Kheng, et al.
Publicado: (2012)

Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma
por: Cunniff, Brian, et al.
Publicado: (2015)

Potential Roles of Exosomes in the Development and Detection of Malignant Mesothelioma: An Update
por: Munson, Phillip, et al.
Publicado: (2022)

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021)

Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014)

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort
por: Amin, Waqas, et al.
Publicado: (2019)

Exploratory use of docetaxel loaded acid-prepared mesoporous spheres for the treatment of malignant melanoma
por: Kaiser, Sameer, et al.
Publicado: (2015)

Heparanase inhibitors restrain mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2018)

Onconase Mediated NFKβ Down-Regulation in Malignant Pleural Mesothelioma
por: Goparaju, Chandra M., et al.
Publicado: (2011)

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
por: Zolondick, Alicia A., et al.
Publicado: (2021)

A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma
por: Nishikawa, Sho, et al.
Publicado: (2014)

Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011)

Malignant mesothelioma presenting as dysphagia diagnosed by endoscopic ultrasound
por: Al-Bawardy, Badr, et al.
Publicado: (2014)

The promyelocytic leukemia zinc finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival
por: Cheung, Mitchell, et al.
Publicado: (2009)

Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2010)

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
por: Sato, Hiroki, et al.
Publicado: (2018)

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis
por: Cheriyan, Vino T., et al.
Publicado: (2014)

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma
por: Guo, Yanan, et al.
Publicado: (2013)

Genomics and Epigenetics of Malignant Mesothelioma
por: Sage, Adam P., et al.
Publicado: (2018)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
por: Pellegrini, Laura, et al.
Publicado: (2017)

CARP-1 Functional Mimetics Are a Novel Class of Small Molecule Inhibitors of Malignant Pleural Mesothelioma Cells
por: Jamal, Shazia, et al.
Publicado: (2014)

Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation
por: Son, Seunghwan, et al.
Publicado: (2019)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Mesothelium and Malignant Mesothelioma
por: Hiriart, Emilye, et al.
Publicado: (2019)

Malignant paratesticular mesothelioma
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
por: Szymiczek, Agata, et al.
Publicado: (2017)

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma
por: Klikovits, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vr2gb37fj2d42shfuakt101auk